Peptides are not a miracle drug | The Economist

Market Overview and Accessibility

• Peptides are being marketed as performance-enhancing drugs for muscle growth, hair restoration, and skin complexion, often sold via unregulated online vendors in China.
• A specific example of accessibility involves purchasing BPC-157 (described as part of a "Wolverine stack") from Chinese sites with no legal barriers.
• Products are sold under loopholes labeling them "research chemicals only," despite sites selling necessary accessories like syringes and bacteriostatic water.
• High-profile figures, including Joe Rogan and RFK Jr., are actively normalizing the use of these untested substances.

Health Risks and Safety Concerns

• There is a complete absence of scientific validation, clinical testing, or regulatory oversight for these specific peptide stacks.
• Product purity is highly questionable; independent testing has revealed bottles containing derivatives of ecstasy, weed killer, and unlisted compounds.
• Long-term biological risks, such as potential cancer triggers from stimulating blood vessel growth, remain entirely unknown.
• Users are bypassing standard safety protocols that exist to protect against unknown side effects of novel biological molecules.

The Role of Internet Culture and "Bro Science"

• The internet has replaced the traditional "gym buddy" supply chain with direct links to Chinese factories and online influencers.
• A mix of plausible biological speculation, wishful thinking, and "folk pharmacology" (or "bro science") drives user behavior.
• The "Silicon Valley crowd" argues that established medicine moves too slowly, pushing for self-experimentation to bypass the 10-year, billion-dollar clinical trial process.
• Anecdotal evidence and "mitochondrial rejuvenation" claims are often conflated with actual science, lacking rigorous data.

Regulatory Responses and Future Outlook

• United States: Regulators are moving toward allowing compounding pharmacies to manufacture certain peptides to ensure a safer supply chain.
• United Kingdom and others: Authorities are cracking down on manufacturing sites and online vendors but have taken little action against social media marketing.
• Experts warn that with hundreds of available peptides, it is statistically impossible to identify the few that may be useful without proper clinical trials.
• There is a consensus that the current unregulated market prioritizes profit and speed over the complex, necessary infrastructure required to understand human biology and drug interactions.